| Model Number |
305C221 |
| Medical Device Problem Code |
Appropriate Device Problem Term/Code Not Available (3191)
|
| Health Effect - Clinical Code |
Cardiovascular Dysfunction/Insufficiency (4445)
|
| Date of Event |
04/21/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that 10 years and 9 months post implant of this 21 mm mosaic aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement.The reason for evaluation was reported as heart failure/hemodynamic instability.No intervention or adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|